Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

s goal to lead in the creation of a new era of patient friendly, body harmonious, medicinal solutions, which are intended to improve the quality of life, increase duration of life and address serious, unmet medical health care needs for patients."

Conferences and Presentations in June 2013American Society of Clinical Oncology 2013 Annual Meeting May 31-June 4, 2013At the upcoming American Society of Clinical Oncology (ASCO) 2013 annual meeting the company will have one oral presentation and three poster presentations on ibrutinib. The oral presentation discusses the Phase I study of ibrutinib combined with R-CHOP in patients with CD20-Positive B-cell frontline NHL (DLBCL, MCL, FL). There will be a poster discussion on tumor genomic profiling revealing mechanisms of resistance to ibrutinib in CLL patients. From our clinical pharmacology team we will also present a poster on pharmacokinetics of dose ranging of ibrutinib in CLL, and another poster on describing safety data with the evaluation of electrocardiograms in CLL patients receiving ibrutinib.

  • Oral Abstract Session
    Phase Ib Study Combining Ibrutinib with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Patients with CD20-Positive B-Cell Non Hodgkin Lymphoma (NHL) Date/Time: June 01, 2013, 1:45PM – 2:00PM, Location: E354a , Author: Dr. Anas Younes
  • Poster Discussion Session
    Use of Tumor Genomic Profiling to Reveal Mechanisms of Resistance to the BTK Inhibitor Ibrutinib in Chronic Lymphocytic Leukemia (CLL)
    Date/Time Poster Display: June 01, 2013, 8:00AM - 12:00PM, Location: S405
    Poster Discussion: 12:00PM - 1:00PM, Location: S406, Author: Dr. Joseph Buggy
  • Poster Session
    Pharmacokinetics of Ibrutinib in Patients with Chronic Lymphocytic Leukemia
    Date/Time: June 02, 2013, 8:00AM - 11:45AM, Location: S Hall A2, Author: Dr. Juthamas Sukbuntherng
  • Poster Session
    Open Label Evaluation of ECG in Pati
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
    9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
    10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
    11. Hospira Reports First-Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... 10, 2014  Breg, Inc., a premier provider ... the FreeRunner™ knee brace with new innovations to ... mal-tracking return to active lifestyles.  FreeRunner,s patent-pending design ... providing support when patients need it most, and ... Patellofemoral issues are the most common ...
    (Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
    (Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
    Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
    (Date:7/11/2014)... 2014 Recently, iFitDress.com, a leading online ... has released its new collection of evening dresses ... has announced that all these beautiful items are provided ... of the special offer is July 22. , ... pay close attention to customer satisfaction. On the company’s ...
    (Date:7/11/2014)... H.E.A.R Me Out Listens to Needs ... week to provide comprehensive information and services available to ... million Coloradoans with hearing loss, this organization is the ... of the local and state resources that aims to ... , H.E.A.R. Me Out and its website was founded ...
    (Date:7/11/2014)... Los Angeles dental implant expert ... and full mouth implants to replace missing teeth. Both ... dental implants from other tooth replacements: They replace the ... alone prevents the long-term complications of missing teeth, but ... comfort, appearance and systemic health. Mini implants broaden candidacy ...
    (Date:7/11/2014)... 2014 Having experienced mental illness from the ... mental hospital staff, Roger Grainger gives readers an intimate look ... new book, “You Never Get Out.” , According to the ... Kingdom will experience some kind of mental health problem in ... to take a look at the way mental illness is ...
    (Date:7/11/2014)... HealthDay Reporter FRIDAY, July 11, ... who can,t cough, sneeze or laugh without losing bladder ... cells to regenerate weakened urethra muscles. In a ... cells isolated from patients, own fat tissue improved or ... Stress incontinence affects about twice as many ...
    Breaking Medicine News(10 mins):Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Psychiatric Hospital Patient and Registered Psychologist Explores Mental Health and Therapy in New Book "You Never Get Out" 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3
    ... bedside patient safety solutions -SAN DIEGO, April 3 ... handheld barcode point-of-care (BPOC) solutions ... Sweeney has been appointed Chairman and CEO.(Logo: ... CEO of eight healthcare service companies including Bridge ...
    ... boost strength in other ways, researchers say , , FRIDAY, April ... mass in octogenarian women but still helped them lift more ... University in Indiana finds. , , The six ... for three months on a machine designed to strengthen the ...
    ... F C, s * ... , Although recent media attention has focused on the presence of ... Protection Agency and the U.S. Food and Drug Administration (FDA) have ... appropriate for all consumers, including sensitive sub-populations like infants. Trace ...
    ... Inc. (Nasdaq: MEDQ ) has announced it has ... of Sales and Marketing. Gold will be responsible for ... of MedQuist. "We are pleased to have Alan join the ... brings an extensive knowledge and an in-depth understanding of healthcare ...
    ... poorer scores on cognitive tests , , FRIDAY, April 3 (HealthDay News) ... life span may be taking a toll on the brains of ... shows that women aged 47 to 74 who tested positive for ... or bones (an indication of cumulative exposure over the life span) ...
    ... & Spa,Group, Inc. (OTC Bulletin Board: SOKF) announced the ... April 1, 2009. The latest SOKO Spa began,offering "pre-opening" ... more,than 500 Spa members since that date. , ... Blessing Hot Spring Business Club,No.332, Xinyang Rd., Daoli District, ...
    Cached Medicine News:Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 2Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 3Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 4Health News:Muscle Mass Won't Grow in Women Over 80 2Health News:International Formula Council (IFC) Reassures Parents about Perchlorate and the Safety of Infant Formula 2Health News:MedQuist Names Alan J. Gold as Senior Vice President, Sales and Marketing 2Health News:Accumulated Lead May Affect Older Women's Brains 2Health News:SOKO Fitness & Spa Group, Inc. Opens Xinyang Spa in Harbin 2
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
    Medicine Products: